Research Project · Health (Hematology/Oncology)
Blood Cancer United Translational Research Program (TRP) 2026-2027
Blood Cancer Unitedbloodcancerunited.org (opens in a new tab)Catalog updated
- Amount
- $750,000
- Program type
- Research Project
- Field
- Health (Hematology/Oncology)
- Eligible career stages
- Not listed
About this program
Blood Cancer United’s Translational Research Program (TRP) funds projects that accelerate promising blood-cancer discoveries toward clinical application, supporting translationally ready small-molecule, cellular and immunotherapy programs in hematologic malignancies. Awards may be up to $250,000 USD per year (maximum $750,000 total for three years), with indirect costs capped at 10% and no more than 40% of direct costs for post‑graduate professional salaries. Applicants must demonstrate translational readiness—in vivo proof of concept is required for small molecules and strongly encouraged for cellular/immunotherapies (select in vitro POC using patient‑derived samples may be acceptable in limited cases); projects should target diseases of high unmet need (e.g., AML, CLL, lymphomas, MM). Submit a Letter of Intent by October 16, 2026 (3:00 PM ET) and full application by January 22, 2027 (3:00 PM ET); a Snowdome Foundation co‑funding opportunity is available for eligible Australian investigators.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 7 similar programs in full.
Ask for a demo of this program The form opens already filled in.